We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Aerpio

News List

Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement firstwordpharma
August 27, 2021
Aadi Bioscience, Inc. ("Aadi") (Nasdaq: AADI) today announced the closing of its previously announced merger with Aerpio Pharmaceuticals, Inc. (previously traded on the Nasdaq Capital Market under "ARPO").
Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients prnewswire
September 03, 2020
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative™ (Quantum Leap) announced dosing of the first patient with razuprotafib in the I-SPY COVID Trial (NCT04488081), a phase 2 platform trial aimed at improving treatment of acute ...
Aerpio, Quantum Leap Select Razuprotafib as Potential Treatment for COVID-19 ARDS americanpharmaceuticalreview
June 02, 2020
Aerpio Pharmaceuticals and Quantum Leap Healthcare Collaborative™ announced an agreement has been reached to evaluate razuprotafib in a new randomized ...
Aerpio Announces Completion of Patient Dosing in AKB-9778 Study americanpharmaceuticalreview
January 21, 2019
Aerpio Pharmaceuticals announced the completion of patient dosing in the company’s TIME-2b study, a Phase 2b clinical trial designed to assess the efficacy and safety of Aerpio’s lead candidate....